SLC17A1 (NPT1) is a sodium-dependent phosphate transporter primarily functioning in renal phosphate resorption via Na+ cotransport at the brush border membrane 1. Beyond phosphate, SLC17A1 mediates urate transport in the kidney and serves as a physiologic urine transporter for the lactate-derived metabolite N-lactoyl-phenylalanine (Lac-Phe), a satiety signal that suppresses food intake 2. SLC17A1 genetic variants significantly impact serum urate levels and disease susceptibility; loss-of-function mutations cause urate underexcretion, contributing to hyperuricemia and gout 3. Polymorphisms rs9467596 and rs2096386 correlate with hyperuricemia risk, particularly when combined with alcohol consumption 4. The p.W75C variant substantially impairs urate transport activity 5. SLC17A1 variants also associate with phthalate metabolite excretion 6 and altered cholesterol homeostasis and homocysteine levels in men 7. Recent linkage analysis identified SLC17A1 variants in familial type 1 diabetes in Kuwaiti populations, suggesting broader metabolic roles beyond urate handling 8. Together, SLC17A1 represents a multifunctional transporter with clinical significance for gout, cardiovascular risk, and potentially autoimmune disease pathogenesis.